New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

Compounds block a protein involved in many cancers by cementing it shut.

Over the next 15 years chronic disease like cancer and heart disease will become major killers in Sub-Saharan Africa. A new report from the Economist Intelligence Unit explains why.

Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

Technology used to tag friends on social media could change the way drug discovery is done.